نتایج جستجو برای: malignant hematologic disorders
تعداد نتایج: 883437 فیلتر نتایج به سال:
background: the aim of this study was to determine the prevalence and characteristics of rheumatologic manifestations associated with mds. methods: eighty patients with mds were evaluated by history and physical examination for inflammatory rheumatologic disorders from jan 2013 to may 2014. patients who had any signs or symptoms of rheumatologic disorders underwent evaluation by laboratory test...
We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic stem cell transplantation (alloSCT) in recipients of solid organ transplantation (SOT). We investigated 28 patients with malignant (N = 22) or nonmalignant diseases (N = 6), who underwent 31 alloSCT procedures: 12 after kidney, 13 after ...
background: the mapping of the malignization mechanism is still incomplete, but oxidative stress is strongly correlated to carcinogenesis. in our research, using fuzzy logic, we aimed to estimate the oxidative stress related-cancerization risk of the oral potentially malignant disorders. methods: serum from 16 patients diagnosed (clinical and histopathological) with oral potentially malignant d...
The presence of terminal deoxynucleotidyl transferase (TdT) has been determined in neoplastic cells from 50 patients with non-hematologic tumors as well as neoplastic cells from 85 patients with hematologic malignancies. The results indicate that TdT is not present in cells from non-hematologic tumors, Hodgkin's lymphoma, B cell lymphoproliferative disorders, peripheral T cell neoplasms, reacti...
The evaluation of hematologic disorders after solid organ transplantation (SOT) must take into account issues unique to the post-transplant setting that influence the development of anemia and single or multi-lineage cytopenias. Attention to the time of onset of cytopenia(s) is important, because the disorders of passenger lymphocyte syndrome, transplant-related thrombotic microangiopathy, hemo...
Indirect immunofluorescence staining with monoclonal antibody (MoAb) CL203.4 of malignant cells from 269 patients with hematologic malignancies showed a heterogeneous expression of CD54/intercellular adhesion molecule-1 (ICAM-1). This marker was expressed by malignant cells of 57 out of 118 patients with myeloid malignancies and 69 out of 135 with B-lymphoid malignancies. On the other hand, CD5...
BACKGROUND Baseline health status influences outcomes of severe sepsis. OBJECTIVE To determine if recent infection is a marker of poor health in patients with hematologic malignant tumors and severe sepsis by modifying the Sequential Organ Failure Assessment (SOFA) score to account for infection. METHODS Medical records of the first 50 patients with hematologic malignant tumors and severe s...
SPAG6, which is a novel cancer-testis antigen, is overexpressed in myeloid malignancies. Previously, SPAG6 was found in UPD (uniparental disomy) region of myeloid cell DNA from MDS patients and reported that SPAG6 may be a predictive marker of minimal residual disease in pediatric acute myeloid, but the biological role of SPAG6 in myeloid malignancies remains unclear. The present study was unde...
Splenic infarction is a clinical entity seldom encountered. The most frequent causes of splenic infarction include thromboembolic phenomena, hematologic malignant neoplasms, and vasculitides. We describe a patient who sustained splenic infarction secondary to diabetes-induced, small-vessel atherosclerotic disease.
A 60-year-old female with Bernard-Soulier and Hemophilia presented to the Emergency Department epistaxis for three days. Despite an extended hospital admission pharmacological, manual, surgical interventions, she failed achieve hemostasis was discharged a nursing facility under hospice care. This case report explores challenges of managing patient chronic complicated by multiple hematologic dis...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید